Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
about
Felbamate as an add-on therapy for refractory epilepsyFelbamate as an add-on therapy for refractory epilepsyFelbamate as an add-on therapy for refractory epilepsyComprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndromeCurrent trends in antiepileptic drug therapy.Phenobarbital for childhood epilepsy: systematic review.Seizure medications: a review for the primary care pediatrician.NMDA receptors in clinical neurology: excitatory times ahead.Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.Clinical practice guidelines and practice parameters for the child neurologist.Newer antiepileptic drugs: evidence based use.Felbamate as an add-on therapy for refractory partial epilepsy.Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.How we treat Bowen's disease with topical photodynamic therapy in Dundee.Randomized controlled trials and assessment of drug safety.Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of t
P2860
Q24194842-C78E4D76-A526-4983-8CBA-F233B5193458Q24234706-82910877-D480-4DCC-927D-38FA8B4316A7Q24239910-AABF59F3-83AE-47B8-A1C3-DE649AD79A37Q26823805-72ED4501-FD9F-4604-AF1B-B20BF6DD3861Q34208307-385A3577-8A3C-4191-AAE8-487194B88A21Q35677374-628891B6-1D60-4FD2-8506-AAF99F92BB60Q36167649-6CEE30B7-C892-478C-960A-11B7C41EA147Q36660216-5DCA9CA8-77E1-4B1D-A68D-6BD0E597AAF8Q37219705-5A44E88F-DB9F-4833-86C9-C05C55E82C53Q38098146-4D3491C1-5E66-45A3-AB4E-5C83226A638AQ38222584-6DDB4D9B-8F5A-460F-8D4E-5AF0CF4ABE81Q38674248-DE0E0840-8791-40E6-A1CA-B73FD6D064D2Q45948057-A5DAB2B4-25CA-40D5-BEF5-AD848447DFA8Q46008893-870D2884-1C68-4615-ABF3-E09BB07E8BCCQ53899392-455494D6-B510-4017-837A-D0309B1B0319Q57543937-3B951FF4-B8E5-4ED8-BF13-1598685A11A8
P2860
Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Practice advisory: The use of ...... the American Epilepsy Society.
@ast
Practice advisory: The use of ...... the American Epilepsy Society.
@en
type
label
Practice advisory: The use of ...... the American Epilepsy Society.
@ast
Practice advisory: The use of ...... the American Epilepsy Society.
@en
prefLabel
Practice advisory: The use of ...... the American Epilepsy Society.
@ast
Practice advisory: The use of ...... the American Epilepsy Society.
@en
P2093
P356
P1433
P1476
Practice advisory: The use of ...... the American Epilepsy Society.
@en
P2093
P304
P356
10.1212/WNL.52.8.1540
P407
P577
1999-05-01T00:00:00Z